Prognostication in thin cutaneous melanomas.

Area of Science:

• Oncology
• Dermatology
• Biomarker Research

Background:

• Thin cutaneous melanoma, while often having a good prognosis, accounts for a significant portion of melanoma-related deaths.
• Despite their commonality, thin melanomas present challenges in accurate prognostication and prediction.
• Sentinel lymph node biopsies in thin melanoma patients infrequently yield positive results, highlighting a need for better prognostic tools.

Purpose of the Study:

• To review recent advancements (last 5 years) in prognostic and predictive biomarkers for thin melanomas.
• To focus on developments in tumor proliferation measures for thin melanoma.
• To discuss challenges in the development, validation, and clinical translation of biomarkers for thin melanoma.

Main Methods:

• Analysis of Surveillance, Epidemiology and End Results (SEER) registry data.
• Review of cohort data from a dedicated melanoma program.
• Focused literature review on prognostic and predictive biomarkers for thin melanoma.

Main Results:

• The presence of dermal mitoses is a significant factor in improving prognostication and prediction for thin melanomas.
• Tumor proliferation measures show promise as valuable biomarkers.
• Current biomarker panels and risk models require further validation and generalization.

Conclusions:

• Dermal mitoses enhance the accuracy of prognosis and prediction in thin melanoma cases.
• Biomarkers reflecting tumor progression biology are essential for optimizing patient management.
• Future efforts must focus on validating, generalizing, and ratifying new biomarkers for clinical use.